Annie Abraham joined Dr. Desmond Schatz’ type 1 diabetes research team in 2006 with more than 20 years experience as a health care recruiter. She coordinates the recruitment effort for the UF TrialNet Clinical Center. Annie sources/markets to identify new TrialNet Affiliate Sites, facilitating the application, on-boarding and training process, and is the resource to our Affiliate Sites for recruitment, outreach, training, and operational issues. Through partnerships with UF Affiliate Sites and Participating Physician Sites in the region, she plans and organizes study-screening events for diabetes camps, JDRF walks, and community events.
Jessica Ferguson, RN, BSN
Ms. Jessica Ferguson is the TrialNet Site Coordinator, overseeing the Oral Insulin, Abatacept, and Anti-CD3 (Teplizumab) prevention studies. Her responsibilities include recruitment and enrollment of new study participants, coordinating and monitoring study visits and procedures, ensuring regulatory and protocol compliance, and participant retention. Jessica trains new TrialNet Affiliate Sites and supports Affiliate Site coordinators with clinical, protocol , and operational issues. Jessica joined the research team after serving as a diabetes nurse educator in pediatrics diabetes clinic. She earned her Bachelor of Science in Nursing and Psychology from the University of Florida.
Madison Smith, RN, BSN
Madison Smith’s interest in T1D research stems from her diagnosis with the disease in 2008. She immersed herself in T1D research, first working with a team performing drug trials in NOD mice. Madison is a Study Coordinator for Pathway to Prevention, recruiting and enrollng participants, assisting with study visits and monitoring procedures, and contributing to TrialNet retention programs. Madison graduated with Honors from the University of Florida in 2014 with her Bachelor of Science in Nursing. She is currently pursuing her graduate degree at UF through the BSN to PhD program and is motivated by the impportance of research in order to discover a cure.
Ms. Miriam Cintron began working with the Diabetes Research Group in 2007 as the Research Coordinator on four clinical studies: Cord Blood Studies (phases 1 and 2), Neulasta/GCSF Study, and the Osiris/Prochymal® Clinical Trial. Ms. Cintron works very closely with Dr. Michael Haller, who is the Principal Investigator (PI) of these studies. Miriam is the coordinator for the TrialNet ATG-GCSF New Onset Study. As research coordinator, her responsibilities include: enrolling and screening of potential study participants, coordinating and monitoring follow-up visits for participants, documenting and maintaining participant files and study regulator documents. In addition, she is also responsible for updating and submitting study documents to the UF Institutional Review Board (IRB). Prior to becoming a part of the UF Diabetes Team, Ms. Cintron received her Bachelor of Science degree from Rutgers University in New Brunswick, NJ, and worked in the research field for over 20 years.
Jennifer Hosford, MPH
Jennifer Hosford earned her Masters of Public Health from the University of Florida. She joined Dr. Schatz’ research team in 2015 with more than 8 years experience as a Clinical Research Coordinator. Prior to joining the TrialNet group she served as a Clinical Research Specialist, Grants Manager and Clinical Trials Expert with the Department of Medicine for five years. Jennifer is the TrialNet Natural History Pathway to Prevention Study Coordinator and the TrialNet Long Term Follow-Up (LIFT) Study Coordinator. Her responsibilities include recruitment and enrollment of new study participants, coordinating and monitoring study visits and procedures, ensuring regulatory and protocol compliance. In addition Jennifer coordinates the TrialNet CGM Metrics and Dysglycemia ancillary Study and the NIH-Funded Human Islet Research Network grant at UF.